ID NUAK1_MOUSE Reviewed; 658 AA. AC Q641K5; Q6I6D6; Q8CGE1; DT 24-JAN-2006, integrated into UniProtKB/Swiss-Prot. DT 25-OCT-2004, sequence version 1. DT 27-MAR-2024, entry version 156. DE RecName: Full=NUAK family SNF1-like kinase 1; DE EC=2.7.11.1; DE AltName: Full=AMPK-related protein kinase 5; DE AltName: Full=Omphalocele kinase 1; GN Name=Nuak1; Synonyms=Kiaa0537, Omphk1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J, and FVB/N; TISSUE=Brain, and Salivary gland; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 84-658. RC TISSUE=Fetal brain; RX PubMed=14621295; DOI=10.1093/dnares/10.4.167; RA Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S., RA Saga Y., Nagase T., Ohara O., Koga H.; RT "Prediction of the coding sequences of mouse homologues of KIAA gene: III. RT The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs RT identified by screening of terminal sequences of cDNA clones randomly RT sampled from size-fractionated libraries."; RL DNA Res. 10:167-180(2003). RN [3] RP DISRUPTION PHENOTYPE, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE. RX PubMed=16715502; DOI=10.1002/dvdy.20823; RA Hirano M., Kiyonari H., Inoue A., Furushima K., Murata T., Suda Y., RA Aizawa S.; RT "A new serine/threonine protein kinase, Omphk1, essential to ventral body RT wall formation."; RL Dev. Dyn. 235:2229-2237(2006). RN [4] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, and Brown adipose tissue; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Serine/threonine-protein kinase involved in various processes CC such as cell adhesion, regulation of cell ploidy and senescence, cell CC proliferation and tumor progression. Phosphorylates ATM, CASP6, LATS1, CC PPP1R12A and p53/TP53. Acts as a regulator of cellular senescence and CC cellular ploidy by mediating phosphorylation of 'Ser-464' of LATS1, CC thereby controlling its stability. Controls cell adhesion by regulating CC activity of the myosin protein phosphatase 1 (PP1) complex. Acts by CC mediating phosphorylation of PPP1R12A subunit of myosin PP1: CC phosphorylated PPP1R12A then interacts with 14-3-3, leading to reduced CC dephosphorylation of myosin MLC2 by myosin PP1. May be involved in DNA CC damage response: phosphorylates p53/TP53 at 'Ser-15' and 'Ser-392' and CC is recruited to the CDKN1A/WAF1 promoter to participate in CC transcription activation by p53/TP53. May also act as a tumor CC malignancy-associated factor by promoting tumor invasion and metastasis CC under regulation and phosphorylation by AKT1. Suppresses Fas-induced CC apoptosis by mediating phosphorylation of CASP6, thereby suppressing CC the activation of the caspase and the subsequent cleavage of CFLAR. CC Regulates UV radiation-induced DNA damage response mediated by CDKN1A. CC In association with STK11, phosphorylates CDKN1A in response to UV CC radiation and contributes to its degradation which is necessary for CC optimal DNA repair. {ECO:0000250|UniProtKB:O60285}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl- CC [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA- CC COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L- CC threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, CC Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; CC EC=2.7.11.1; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; CC -!- ACTIVITY REGULATION: Activated by phosphorylation on Thr-212. Activated CC by phosphorylation at Ser-601 AKT1 during glucose starvation; the CC relevance of such activation in normal cells is however unsure (By CC similarity). {ECO:0000250}. CC -!- SUBUNIT: Interacts (via GILK motif) with PPP1CB; the interaction is CC direct and bridges NUAK1 and PPP1R12A. Interacts with CDKN1A. CC {ECO:0000250|UniProtKB:O60285}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. CC -!- TISSUE SPECIFICITY: Expressed in the developing central nervous system, CC in epidermis, and some other tissues. {ECO:0000269|PubMed:16715502}. CC -!- DEVELOPMENTAL STAGE: At 7.5 dpc, expressed in allantois and anterior CC visceral endoderm. In the embryonic part, present in mesoderm migrating CC laterally but not in the primitive streak; the expression is not CC apparent in ectoderm or endoderm at this stage. At 8.5 dpc, no CC expression is found in mesodermal tissues, while it is expressed in CC midbrain and isthmic regions of the neuroectoderm; it is also found in CC the pharyngeal region of the foregut. At 9.5 dpc, the expression is CC found throughout the undifferentiated neuroectoderm, except the CC telencephalic region. The expression is also ubiquitous in the CC epidermis; it is especially apparent in the ventral body wall. Also CC expressed in dorsal root ganglia of neural crest origin. The expression CC persists in the anterior gut and is also found in bulb arteriosus, CC kidney, and several connective tissues. At 12.5 dpc, the expression is CC greatly reduced in most of the neuroectoderm, but some expression CC remains in pons, anterior tectum, tegmentum, pretectum, prethalamus, CC mammillary region and hypothalamus. In telencephalon, expression is CC present in the differentiating preplate of the cortex. The expression CC is sustained in the epidermis of the whole body. In 14.5 and 18.5 dpc CC brain, expressed in differentiated fields of the cortex; no significant CC expression is found in other parts of brain or in the spinal cord. The CC expression is also present in a variety of connective tissues and in CC the epidermis of the whole body. {ECO:0000269|PubMed:16715502}. CC -!- DOMAIN: The GILK motif mediates interaction with PPP1CB. {ECO:0000250}. CC -!- PTM: Phosphorylated at Thr-212 by STK11/LKB1 in complex with STE20- CC related adapter-alpha (STRADA) pseudo kinase and CAB39. Not CC dephosphorylated by the myosin PP1 complex when regulating its CC activity, due to the presence of PPP1R12A, which prevents myosin PP1 CC from dephosphorylating NUAK1. Phosphorylated by STK38L upon stimulation CC with IGF1 (By similarity). {ECO:0000250}. CC -!- PTM: Ubiquitinated with 'Lys-29'- and 'Lys-33'-linked polyubiquitins CC which appear to impede LKB1-mediated phosphorylation. Deubiquitinated CC by USP9X (By similarity). {ECO:0000250}. CC -!- DISRUPTION PHENOTYPE: Lethal during development, no live-born. At 18.5 CC dpc, homozygous mutants suffer from omphalocele with a failure in CC closure of the secondary body wall leading to organs outside of the CC abdomen. Omphalocele are apparent at 14.5 dpc when the physiological CC hernia is almost rectified in wild-type embryos. CC {ECO:0000269|PubMed:16715502}. CC -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr CC protein kinase family. SNF1 subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BC040467; AAH40467.1; -; mRNA. DR EMBL; BC082328; AAH82328.1; -; mRNA. DR EMBL; AB182364; BAD23995.1; -; mRNA. DR CCDS; CCDS24079.1; -. DR RefSeq; NP_001004363.1; NM_001004363.1. DR AlphaFoldDB; Q641K5; -. DR SMR; Q641K5; -. DR BioGRID; 219063; 1. DR STRING; 10090.ENSMUSP00000020220; -. DR iPTMnet; Q641K5; -. DR PhosphoSitePlus; Q641K5; -. DR MaxQB; Q641K5; -. DR PaxDb; 10090-ENSMUSP00000020220; -. DR ProteomicsDB; 252864; -. DR Antibodypedia; 30646; 339 antibodies from 36 providers. DR DNASU; 77976; -. DR Ensembl; ENSMUST00000020220.15; ENSMUSP00000020220.9; ENSMUSG00000020032.15. DR GeneID; 77976; -. DR KEGG; mmu:77976; -. DR UCSC; uc007gko.1; mouse. DR AGR; MGI:1925226; -. DR CTD; 9891; -. DR MGI; MGI:1925226; Nuak1. DR VEuPathDB; HostDB:ENSMUSG00000020032; -. DR eggNOG; KOG0611; Eukaryota. DR GeneTree; ENSGT00940000157255; -. DR HOGENOM; CLU_000288_63_42_1; -. DR InParanoid; Q641K5; -. DR OMA; VCDCDTL; -. DR OrthoDB; 5475340at2759; -. DR PhylomeDB; Q641K5; -. DR TreeFam; TF324572; -. DR Reactome; R-MMU-6804756; Regulation of TP53 Activity through Phosphorylation. DR BioGRID-ORCS; 77976; 1 hit in 81 CRISPR screens. DR ChiTaRS; Nuak1; mouse. DR PRO; PR:Q641K5; -. DR Proteomes; UP000000589; Chromosome 10. DR RNAct; Q641K5; Protein. DR Bgee; ENSMUSG00000020032; Expressed in interventricular septum and 241 other cell types or tissues. DR ExpressionAtlas; Q641K5; baseline and differential. DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB. DR GO; GO:0001650; C:fibrillar center; ISO:MGI. DR GO; GO:0015630; C:microtubule cytoskeleton; ISO:MGI. DR GO; GO:0005654; C:nucleoplasm; ISO:MGI. DR GO; GO:0031588; C:nucleotide-activated protein kinase complex; IBA:GO_Central. DR GO; GO:0005634; C:nucleus; ISS:UniProtKB. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0002039; F:p53 binding; ISO:MGI. DR GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA. DR GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB. DR GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW. DR GO; GO:0042149; P:cellular response to glucose starvation; IBA:GO_Central. DR GO; GO:0006974; P:DNA damage response; IEA:UniProtKB-KW. DR GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central. DR GO; GO:0032007; P:negative regulation of TOR signaling; IBA:GO_Central. DR GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB. DR GO; GO:0030155; P:regulation of cell adhesion; ISS:UniProtKB. DR GO; GO:2000772; P:regulation of cellular senescence; ISS:UniProtKB. DR GO; GO:0035507; P:regulation of myosin-light-chain-phosphatase activity; ISS:UniProtKB. DR CDD; cd14073; STKc_NUAK; 1. DR Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1. DR InterPro; IPR011009; Kinase-like_dom_sf. DR InterPro; IPR000719; Prot_kinase_dom. DR InterPro; IPR017441; Protein_kinase_ATP_BS. DR InterPro; IPR008271; Ser/Thr_kinase_AS. DR PANTHER; PTHR24346; MAP/MICROTUBULE AFFINITY-REGULATING KINASE; 1. DR PANTHER; PTHR24346:SF101; NUAK FAMILY SNF1-LIKE KINASE 1; 1. DR Pfam; PF00069; Pkinase; 1. DR SMART; SM00220; S_TKc; 1. DR SUPFAM; SSF56112; Protein kinase-like (PK-like); 1. DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1. DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1. DR PROSITE; PS00108; PROTEIN_KINASE_ST; 1. DR Genevisible; Q641K5; MM. PE 1: Evidence at protein level; KW Acetylation; ATP-binding; Cell adhesion; Cytoplasm; DNA damage; Kinase; KW Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome; KW Serine/threonine-protein kinase; Transferase; Ubl conjugation. FT CHAIN 1..658 FT /note="NUAK family SNF1-like kinase 1" FT /id="PRO_0000086454" FT DOMAIN 56..307 FT /note="Protein kinase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT REGION 1..53 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 353..422 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 441..568 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 400..403 FT /note="GILK motif" FT COMPBIAS 364..378 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 474..501 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 179 FT /note="Proton acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159, FT ECO:0000255|PROSITE-ProRule:PRU10027" FT BINDING 62..70 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT BINDING 85 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0000250|UniProtKB:O60285" FT MOD_RES 22 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O60285" FT MOD_RES 212 FT /note="Phosphothreonine; by LKB1" FT /evidence="ECO:0000250|UniProtKB:O60285" FT MOD_RES 456 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O60285" FT MOD_RES 601 FT /note="Phosphoserine; by PKB/AKT1" FT /evidence="ECO:0000250|UniProtKB:O60285" SQ SEQUENCE 658 AA; 73661 MW; E7176F13B75B899F CRC64; MEGAAVSAAG DGPAVETGLP GSPLEAVAGA TAAPVEPRKP HGVKRHHHKH NLKHRYELQE TLGKGTYGKV KRATERFSGR VVAIKSIRKD KIKDELDMVH IRREIEIMSS LNHPHIISIY EVFENKDKIV IIMEYASKGE LYDYISERRR LSERETRHFF RQIVSAVHYC HKNGVVHRDL KLENILLDDN CNIKIADFGL SNLYQKDKFL QTFCGSPLYA SPEIVNGRPY RGPEVDSWAL GVLLYTLIYG TMPFDGFDHK NLIRQISSGE YREPTQPSDA RGLIRWMLMV NPDRRATIED IANHWWVNWG YKSSVCDCDA LPDSESPLLA RIIDWHHRST GLQAEAEAKM KGLAKPGASE VVLERQRSLK KSKKENDFPQ SGQDSVPESP SKLSSKRPKG ILKKRSNSEH RSHSTGFIEG IVSPALPSPF KMEQDLCRTA IPLPSSPEAD MSGKLSLKQS ATMPKKGILK KTQQRESGYY SSPERSESSE LLDSNDVVIS GGLSSPPPDP ARGTSHSLSC RRKGILKHSS RYSDGGTDPA LTRPEMPTLE SLSPPGVPSD GISRSYSRPS SIISDDSVLS SDSFDLLELQ ENRPARQRIR SCVSAENFLQ LQDFETPHNR PRPQYLKRLA DSSFSLLTDM DDVTQVYKKA LEICSKLN //